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The purpose of this research was to design and evaluate the olanzapine fast dissolving tablets.  The variable formulation of 
Olanzapine having challenging methodology. Olanzapine practically insoluble in water so used different polymers and 
superdisintigrant to make formulation. Direct compression are most desired method for preparation of mouth dissolving tablets. The 
tablets were evaluated for disintegration and dissolution properties of the formulation. In formulation of mouth dissolving tablet 
evaluate the precompression parameter and post compression parameter and after evaluation found satisfactory 
  
INTRODUCTION 
Oral route of drug administration are the most effective route 
and this route are mainly desired for drug administration. Oral 
routes of drug administration have wide acceptance up to 50-
60% of total dosage forms.  Solid dosage forms are popular 
because of easiness of administration, accurate dosage, self-
medication, pain avoidance and most importantly the patient 
compliance. The most popular solid dosage forms are being 
tablets and capsules; one important drawback of this dosage 
forms for some patients, is the difficulty to swallow. For 
swallowing of oral dosage form drinking water plays an 
important role.  Often times people experience inconvenience 
in swallowing conventional  dosage  forms  such  as  tablet  
when  water  is  not  available,  in  the  case  of  the  motion  
sickness (kinetosis) and sudden episodes of coughing during 
the common cold, allergic condition and bronchitis.  For these 
reason, tablets that can rapidly dissolve or disintegrate in the 
oral cavity have involved a great deal of responsiveness. Mouth 
dissolving tablet is mainly for those who heaving   problem in 
swallowing but also effective or ideal  for active people1.    
 
Preparation of Mouth dissolving tablet: 
Mouth dissolving tablet using different active and excipients 
such as Olanzapine, Sodium Starch Glycollate, Cross 
Caramellose Sodium,  crosspovidone,Talc, Aspartame.Orange 
flavor. Shift the material using 60# and others. Purified water 
are used as binding agent in formulation. After completed 
binding stage dried the granules. Lubricants are added in 
granules and mixed the all lubricants except magnesium 
stearatefor 5 min and after that mix magnesium stearate for 2 
min after lubrication collect the granules & using compression 
machine compressed the granules directly and make the mouth 
dissolving tablets. 
 
Precompresssion Parameter: 
Angle of repose (θ) 
It is defined as the maximum angle possible between the 
surface of a pile of powder and the horizontal plane. 
 
Bulk Density 
It is the ratio of total mass of powder (M) to the bulk volume 
(Vb). Apparent bulk density was determined by pouring 
presieved drug excipient blend into a graduated cylinder and 
measuring the volume and weight.  
 
Tapped Density:   
It is the ratio of total mass of powder to the taped volume of 
powder. 
 
Carr’s compressibility Index:-  
It indicate the flow property of the powder. It is expressed in 
percentage. 
 
Hausner Ratio: 
It is an indirect index of ease of powder flow.  Hausner  found 
and showed that powders with low inter particle friction. Such 
as coarse sphere, have ratios of approximately 1.2 where as 
more cohesive, less free flowing powders such as flakes have 
Hausner’s ratio greater than 1.6. 
 
Post compression Parameter 
Shape and Colour of tablets 
Uncoated tablets were examined under a lens for the shape of 
the tablet and colour was observed by keeping the tablets in 
light. 
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Weight variation 
The tablets were selected randomly from each batch and 
weighed individually to check weight variation. The U.S 
Pharmacopoeia allows a little variation in the weight of a 
tablet. 
 
Hardness 
Tablet crushing strength the critical parameter was controlled 
as tablet capping its depend on hardness of the tablet.  
 
Thickness
 
Thickness is also important parameter for tablet as it affects 
other parameters. 
 
Wetting time 
Water absorption ratio gives insight into disintegration 
properties of the tablets.  
 
In- vitro disintegration time 
Disintegration test is an important parameter of mouth 
dissolving tablets. It is mainly important of absorption of solid 
dosage form after oral administration. Disintegration time 
mainly affected of particle size. Tablet compaction force and 
hardness of tablet mainly affected the tablet disintegration time. 
 
Dissolution profile 
Dissolution testing is widely used in pharmaceutical industry 
for optimization of formulation and quality control. 
 
Table 1: Formulation of olanzapine tablets  
Ingredient F1 F2 F3 F4 F5 F6 F7 F8 F9 
Olanzapine 15 15 15 15 15 15 15 15 15 
Lactose 45 40 45 40 45 40 35 35 35 
Sodium Starch Glycollate 5 10 - - - - - 15 - 
Cross Caramellose Sodium - - 5 10 - - 15 - - 
Crosspovidone  - - - - 5 10 - - 15 
Magnesium stearate 2 2 2 2 2 2 2 2 2 
Talc 2 2 2 2 2 2 2 2 2 
Aspartame 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Orange flavour 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Water q.s q.s q.s q.s q.s q.s q.s q.s q.s 
Total weight 70 70 70 70 70 70 70 70 70 
 
Table 2: Result of precompression evaluation 
 
Formulation 
code 
Angle of  
Repose (θ) 
Bulk Density 
(g/ml) 
Tapped 
Density (g/ml) 
Carr’s Index 
(%) 
Hausner 
Ratio 
F1 22.84 0.467 0.592 14.10 1.15 
F2 26.45 0.498 0.536 12.68 1.13 
F3 20.44 0.416 0.554 12.33 1.12 
F4 23.43 0.482 0.592 13.41 1.15 
F5 24.76 0.434 0.547 12.73 1.13 
F6 22.56 0.466 0.556 13.86 1.16 
F7 21.11 0.482 0.517 14.09 1.17 
F8 23.33 0.411 0.519 13.72 1.19 
F9 25.34 0.568 0.528 14.11 1.13 
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Table 3: Result of post compression evaluation 
Formula– 
tion  code 
Appear
– ance 
Thickness  
(mm) 
Hardness 
(Kg/cm2) 
Friability 
% 
Weight 
variation  
(mg) 
Wetting 
time 
(Sec) 
Disintegration 
Time  
(sec) 
Dissolution 
(%)  
Drug 
content 
(%) 
F1 OK 2.58 3.0 0.22 74 16 56   82.26  96.52  
F2 OK 2.56 3.5 0.32 75 24 120   89.74  96.32  
F3 OK 2.57 3.5 0.29 74 28 72   88.56  96.54  
F4 OK 2.64 2.0 0.33 76 30 62   96.62  97.63  
F5 OK 2.57 2.0 0.26 73 25 59   96.72  97.76  
F6 OK 2.57 3.5 0.40 74 31 72   96.41  97.12  
F7 OK 2.59 3.5 0.39 75 28 150   96.11  96.44  
F8 OK 2.62 3.5 0.29 76 27 144   93.23  96.56  
F9 OK 2.63 3.0 0.31 75 24 204   91.12  96.51  
 
CONCLUSION 
OLZ is atypical antipsychotic agent and used for preparation 
of mouth dissolving tablets. Disintigration studies confirmed 
using sodium starch glycollate and observed faster 
disintegration rate.Dissolution study confirmed with using 
cross carmellose sodium,  crosspovidone   and shows the 
better n dissolution  rate.Formulation F4 and Formulation F5 
give the best result as per mouth dissolving tablets. Addition 
of crosspovidone  in formulation give the minimum 
disintegration time and also shows better dissolution 
result.Which type of formulation shows that lower hardness 
heaving that better disintegration rate and also dissolution rate. 
In prepared formulation F4 And F5 formulation are those 
which heaving lower hardness and shows good disintegration 
and dissolution result.  
 
REFERENCES  
1. Reddy LH, Ghosh B and Rajneesh. Fast dissolving drug 
delivery system: A review of literature. Indian J Pharm 
Sci 2002; 64 (4): 331‐336. 
2. Sharma S, et alnew generation of tablets; Fast dissolving 
tablet. Pharmainfo.net. 
3. Pandina GJ et al, Risperidone improves behavioral 
symptoms in children with autism in a randomized, 
double- blind, placebocontrolled tria. J Autism Dev 
Disord 2007, 37: 367- 373. 
4. Koizumi K, Watanabe Y, Morita K, Utoguchi N and 
Matsumoto M: New method of preparing high porosity 
rapidly saliva soluble compressed tablets using mannitol 
with camphor, a subliming material. Int J Pharm. 1997; 
152:127-131.  
5. Chang R, Gua X, Burnside B and Couch R: A Review of 
Fast Dissolving Tablets. Pharmaceutical 
technology.(North America);June 2000:52-58.  
6. Bi Y, Sunada H, Yonezawa Y, Dayo K, Otsuka A and 
Iida K. Preparation and evaluation of a compressed tablet 
rapidly disintegrating in oral cavity. Chem. Pharm. Bull. 
(1996) 44: 2121-27.  
7. Burton, Michael E.; Shaw, Leslie M.; Schentag, Jerome 
J.; Evans, William E. (May 1, 2005). Applied 
Pharmacokinetics & Pharmacodynamics: Principles of 
Therapeutic Drug Monitoring (4th ed.). Lippincott 
Williams & Wilkins. p. 815. 
8. McGlashan TH, Zipursky RB, Perkins D, Addington J, 
Miller T, Woods SW, Hawkins KA, et al. Randomized, 
double-blind trial of olanzapine versus placebo in patients 
prodromally symptomatic for psychosis. Am J Psychiatry. 
2006;163(5):790-799. 
9. Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: 
A review. Indian Drugs 2004; 41: 187-193. 
10. C. Narendra, M.S. Srinath and B. Prakash: Development 
of Three Layered Buccal Compact Containing Metoprolol 
Tartrate By Statistical Optimization Technique. 
International Journal of Pharmaceutics; 304, 2005: 102-
114. 
11. Allen LV and Wang B. Particulate support matrix for 
making rapidly dissolving tablets. US Patent 1997; No. 
5,595,761. 
Journal of Applied Pharmaceutical Research ISSN No. 2348 – 0335 www.japtronline.com 
 
 
January – March 2015 Volume 3                                       Issue 1  21 
 
Received  09th November 2014 
Revised 18th November 2014 
Accepted  29th November2014 
J. App. Pharm. Res., 3 (1); 2015: 18 – 21 
12. Chavan BS, Sidana A, Singh GP. Olanzapine induced 
mania: A case report. Indian J Psychiatry 2003, 45(I), 56-
57. 
13. Habib W, Khankari R, Hontz J. Fast-dissolving drug 
delivery systems, critical review in therapeutics. Drug 
Carrier Systems 2000; 17(1): 61-72. 
